NASDAQ:AXDX

Accelerate Diagnostics News Headlines

$8.06
-0.03 (-0.37 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$7.85
Now: $8.06
$8.19
50-Day Range
$7.99
MA: $9.03
$10.29
52-Week Range
$6.82
Now: $8.06
$19.11
Volume194,953 shs
Average Volume546,138 shs
Market Capitalization$493.48 million
P/E RatioN/A
Dividend YieldN/A
Beta2.35

Headlines

Accelerate Diagnostics (NASDAQ AXDX) News Headlines Today

SourceHeadline
$3.55 Million in Sales Expected for Accelerate Diagnostics, Inc. (NASDAQ:AXDX) This Quarter$3.55 Million in Sales Expected for Accelerate Diagnostics, Inc. (NASDAQ:AXDX) This Quarter
americanbankingnews.com - April 18 at 1:44 AM
-$0.33 Earnings Per Share Expected for Accelerate Diagnostics, Inc. (NASDAQ:AXDX) This Quarter-$0.33 Earnings Per Share Expected for Accelerate Diagnostics, Inc. (NASDAQ:AXDX) This Quarter
americanbankingnews.com - April 17 at 11:54 AM
Accelerate Diagnostics, Inc. Common Stock (AXDX)Accelerate Diagnostics, Inc. Common Stock (AXDX)
nasdaq.com - April 15 at 1:53 AM
Accelerate Diagnostics (NASDAQ:AXDX)  Shares Down 3.3% Accelerate Diagnostics (NASDAQ:AXDX) Shares Down 3.3%
americanbankingnews.com - April 14 at 2:34 PM
Accelerate, Powered by NetVU, Promises to Be Bigger, Better Than EverAccelerate, Powered by NetVU, Promises to Be Bigger, Better Than Ever
businesswire.com - April 9 at 7:43 PM
Accelerate Diagnostics (NASDAQ:AXDX) Trading Down 5.1%Accelerate Diagnostics (NASDAQ:AXDX) Trading Down 5.1%
americanbankingnews.com - April 7 at 1:04 PM
Accelerate Diagnostics Target of Unusually Large Options Trading (NASDAQ:AXDX)Accelerate Diagnostics Target of Unusually Large Options Trading (NASDAQ:AXDX)
americanbankingnews.com - April 6 at 6:22 AM
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Expected to Post Quarterly Sales of $3.55 MillionAccelerate Diagnostics, Inc. (NASDAQ:AXDX) Expected to Post Quarterly Sales of $3.55 Million
americanbankingnews.com - April 1 at 9:30 AM
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Expected to Announce Earnings of -$0.33 Per ShareAccelerate Diagnostics, Inc. (NASDAQ:AXDX) Expected to Announce Earnings of -$0.33 Per Share
americanbankingnews.com - March 30 at 5:06 AM
News for Accelerate Diagnostics IncNews for Accelerate Diagnostics Inc
markets.businessinsider.com - March 21 at 11:42 PM
Analysts Have Just Cut Their Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Revenue Estimates By 27%Analysts Have Just Cut Their Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Revenue Estimates By 27%
finance.yahoo.com - February 28 at 8:43 AM
Accelerate Diagnostics, Inc. (AXDX) CEO Jack Phillips on Q4 2020 Results - Earnings Call TranscriptAccelerate Diagnostics, Inc. (AXDX) CEO Jack Phillips on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - February 25 at 7:23 AM
Are Insiders Buying Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Stock?Are Insiders Buying Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Stock?
finance.yahoo.com - February 6 at 8:37 AM
Accelerate Diagnostics schedules call to review 2020 fourth quarter and full year resultsAccelerate Diagnostics schedules call to review 2020 fourth quarter and full year results
finance.yahoo.com - February 1 at 1:30 PM
Accelerate Diagnostics to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 18, 2020, at 4:00 p.m. Eastern TimeAccelerate Diagnostics to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 18, 2020, at 4:00 p.m. Eastern Time
finance.yahoo.com - February 1 at 1:30 PM
Top 10 Short Positions Held By Hedge Funds TodayTop 10 Short Positions Held By Hedge Funds Today
finance.yahoo.com - January 29 at 5:54 PM
Levi & Korsinsky, LLP, National Class Action Law Firm, Announces Class Action Investigation Against Robinhood and other Brokers on Behalf of Investors of AXDX and other stocks Who Were Prevented from TradingLevi & Korsinsky, LLP, National Class Action Law Firm, Announces Class Action Investigation Against Robinhood and other Brokers on Behalf of Investors of AXDX and other stocks Who Were Prevented from Trading
finance.yahoo.com - January 28 at 7:53 PM
Accelerate Diagnostics Announces Preliminary Fourth Quarter and Full-Year 2020 Financial ResultsAccelerate Diagnostics Announces Preliminary Fourth Quarter and Full-Year 2020 Financial Results
finance.yahoo.com - January 12 at 6:26 AM
Is AXDX A Good Stock To Buy Now?Is AXDX A Good Stock To Buy Now?
finance.yahoo.com - December 14 at 12:09 PM
Earnings Release: Heres Why Analysts Cut Their Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Price Target To US$15.00Earnings Release: Here's Why Analysts Cut Their Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Price Target To US$15.00
nasdaq.com - November 7 at 8:38 AM
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Just Reported, And Analysts Assigned A US$15.00 Price TargetAccelerate Diagnostics, Inc. (NASDAQ:AXDX) Just Reported, And Analysts Assigned A US$15.00 Price Target
finance.yahoo.com - November 7 at 8:38 AM
Accelerate Diagnostics, Inc. to Host Earnings CallAccelerate Diagnostics, Inc. to Host Earnings Call
finance.yahoo.com - November 5 at 7:01 PM
Accelerate Diagnostics Reports Third Quarter 2020 Financial ResultsAccelerate Diagnostics Reports Third Quarter 2020 Financial Results
finance.yahoo.com - November 5 at 7:01 PM
Accelerate Diagnostics Announces Preliminary First Quarter Financial Results and Provides COVID-19 Business Updates; SchedulesAccelerate Diagnostics Announces Preliminary First Quarter Financial Results and Provides COVID-19 Business Updates; Schedules
bloomberg.com - September 30 at 6:07 PM
Accelerate Diagnostics bags new FDA clearance for Accelerate Phenotest improvementsAccelerate Diagnostics bags new FDA clearance for Accelerate Phenotest improvements
seekingalpha.com - September 16 at 1:57 PM
Accelerate Diagnostics Announces New FDA Clearance for Accelerate PhenoTest® ImprovementsAccelerate Diagnostics Announces New FDA Clearance for Accelerate PhenoTest® Improvements
finance.yahoo.com - September 16 at 1:57 PM
Accelerate Diagnostics announces FDA emergency use nod for individual COVID-19 testsAccelerate Diagnostics announces FDA emergency use nod for individual COVID-19 tests
seekingalpha.com - September 10 at 10:19 AM
Accelerate Diagnostics Announces FDA Emergency Use Authorization for COVID-19 Individual IgM and IgG Antibody TestsAccelerate Diagnostics Announces FDA Emergency Use Authorization for COVID-19 Individual IgM and IgG Antibody Tests
finance.yahoo.com - September 10 at 10:19 AM
Accelerate Diagnostics Names Nedal Safwat Chief Strategy OfficerAccelerate Diagnostics Names Nedal Safwat Chief Strategy Officer
finance.yahoo.com - August 24 at 10:06 AM
Notable Wednesday Option Activity: AXDX, AZO, PLUGNotable Wednesday Option Activity: AXDX, AZO, PLUG
nasdaq.com - August 19 at 5:27 PM
The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOsThe Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs
finance.yahoo.com - August 19 at 12:26 PM
Accelerate Diagnostics Announces Emergency Use Authorization for Covid-19 Antibody TestAccelerate Diagnostics Announces Emergency Use Authorization for Covid-19 Antibody Test
finance.yahoo.com - August 19 at 12:26 PM
Accelerate Diagnostics Pops 10% On US Emergency Use Nod For Covid-19 TestingAccelerate Diagnostics Pops 10% On US Emergency Use Nod For Covid-19 Testing
finance.yahoo.com - August 19 at 7:26 AM
Accelerate Diagnostics up 13% on FDA emergency use nod for COVID-19 testAccelerate Diagnostics up 13% on FDA emergency use nod for COVID-19 test
seekingalpha.com - August 18 at 8:39 PM
Accelerate Diagnostics Announces FDA Emergency Use Authorization for COVID-19 Antibody Testing SystemAccelerate Diagnostics Announces FDA Emergency Use Authorization for COVID-19 Antibody Testing System
finance.yahoo.com - August 18 at 8:39 PM
Accelerate Diagnostics (AXDX) CEO Jack Phillips on Q2 2020 Results - Earnings Call TranscriptAccelerate Diagnostics (AXDX) CEO Jack Phillips on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 8 at 9:00 AM
Accelerate Diagnostics Reports Second Quarter 2020 Financial Results & Announces New Product OfferingAccelerate Diagnostics Reports Second Quarter 2020 Financial Results & Announces New Product Offering
benzinga.com - August 8 at 3:58 AM
Accelerate Diagnostics EPS misses by $0.01, misses on revenueAccelerate Diagnostics EPS misses by $0.01, misses on revenue
seekingalpha.com - August 6 at 8:21 PM
Accelerate Diagnostics Schedules Call to Review Second Quarter 2020 ResultsAccelerate Diagnostics Schedules Call to Review Second Quarter 2020 Results
finance.yahoo.com - July 16 at 9:18 AM
Arizona biotech firm execs agree to pay cutArizona biotech firm execs agree to pay cut
www.bizjournals.com - July 7 at 10:54 PM
Accelerate Diagnostics Inc (AXDX): Hedge Funds Are Snapping UpAccelerate Diagnostics Inc (AXDX): Hedge Funds Are Snapping Up
finance.yahoo.com - June 25 at 6:40 PM
Faruqi & Faruqi, LLP is Investigating Accelerate Diagnostics, Inc. (AXDX) on Behalf of its ShareholdersFaruqi & Faruqi, LLP is Investigating Accelerate Diagnostics, Inc. (AXDX) on Behalf of its Shareholders
finance.yahoo.com - June 15 at 1:31 PM
Accelerate Diagnostics (AXDX) Moves to Strong Buy: Rationale Behind the UpgradeAccelerate Diagnostics (AXDX) Moves to Strong Buy: Rationale Behind the Upgrade
finance.yahoo.com - May 29 at 12:39 PM
How Accelerate Diagnostics (AXDX) Stock Stands Out in a Strong IndustryHow Accelerate Diagnostics (AXDX) Stock Stands Out in a Strong Industry
finance.yahoo.com - May 26 at 2:32 PM
Accelerate Diagnostics, Inc. (AXDX) CEO Jack Phillips on Q1 2020 Results - Earnings Call TranscriptAccelerate Diagnostics, Inc. (AXDX) CEO Jack Phillips on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 11:55 PM
Accelerate Diagnostics (AXDX) Q1 2020 Earnings Call TranscriptAccelerate Diagnostics (AXDX) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 9 at 11:55 PM
Edited Transcript of AXDX earnings conference call or presentation 7-May-20 8:30pm GMTEdited Transcript of AXDX earnings conference call or presentation 7-May-20 8:30pm GMT
finance.yahoo.com - May 8 at 8:09 AM
AXDX Accelerate Diagnostics, Inc. Common StockAXDX Accelerate Diagnostics, Inc. Common Stock
www.nasdaq.com - May 7 at 5:07 PM
Accelerate Diagnostics EPS misses by $0.02, beats on revenueAccelerate Diagnostics EPS misses by $0.02, beats on revenue
seekingalpha.com - May 7 at 5:07 PM
Accelerate Diagnostics Announces First Quarter Financial Results and Provides COVID-19 Business UpdatesAccelerate Diagnostics Announces First Quarter Financial Results and Provides COVID-19 Business Updates
finance.yahoo.com - May 7 at 5:07 PM
This page was last updated on 4/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.